Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. - Wikidata - awgldk - TriplyDB

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.

http://www.wikidata.org/entity/Q36370322

about

Invariant NKT cells as novel targets for immunotherapy in solid tumors Role of CD1d-restricted NKT cells in microbial immunity Autoimmune disease triggered by infection with alphaproteobacteria Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis mTOR Regulation of Lymphoid Cells in Immunity to Pathogens Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation NKT cell networks in the regulation of tumor immunity The immunoregulatory role of type I and type II NKT cells in cancer and other diseases A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Invariant NKT cells sustain specific B cell responses and memory.Sublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challenge.Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.Vaccine-induced myeloid cell population dampens protective immunity to SIV Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.The stimulating adventure of KRN 7000.Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activation Application of nanotechnologies for improved immune response against infectious diseases in the developing world One-pot syntheses of immunostimulatory glycolipids Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2.In vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models.NKT cells in sepsis.Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection Exploiting dendritic cells to improve vaccine efficacy.Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi.Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.The CD1 family and T cell recognition of lipid antigens.Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells.Regulatory T cells in the control of transplantation tolerance and autoimmunity.Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells Specific deletion of LDL receptor-related protein on macrophages has skewed in vivo effects on cytokine production by invariant natural killer T cells.Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis.Synthesis and Biological Activities of 5-Thio-α-GalCers.

P2860

Q21284987-A3419DD8-063A-4C19-95A6-50A6B1515F17 Q24294851-B0AD2484-D98B-4300-8BE5-361F5C5587D6 Q24655779-60C3C542-4BD2-4E4C-A584-FFC150146408 Q26738653-5ED04B36-34BC-4B5E-8738-1E297F120212 Q26744649-EA9CAE48-19C5-4CF7-9FCF-82C997E89A5B Q26748456-BBC01CA1-CE63-491E-90CA-8206653DA3DA Q26768699-1B2AACA1-7C4B-44F5-896C-CC854AC2196F Q26797344-8302D80A-B1DC-4659-9B91-B33EB4C06DEE Q26866223-94BF41DE-01DF-452A-A7A8-AE77DA0E1ED4 Q27027556-A030FF1B-E215-499B-9B3F-CB0164B3D4D2 Q27303293-10436946-098B-4C48-8198-5E46925C0BA4 Q30374900-91107B8F-5FFF-465E-A49A-44ABA9ED0C08 Q30377447-21E67231-C2A0-4F61-B704-F3CCABBB9CDA Q30479030-90A63825-1AC5-4327-9E86-BEB6506596E0 Q31153121-C2DFA078-888B-42A3-A859-3F76F002B8FC Q33390790-A9CE0A94-5DE9-45B8-A372-8472B51BF987 Q33628422-EEBD34BD-E631-4058-9DD7-20F19683A229 Q33685961-F9BBD79E-D34F-4E71-818A-5689C4700933 Q33792633-BFA4C474-6F59-4634-8DEE-32BC6B4F0565 Q33843406-1D6F3C31-CFED-419C-B65C-3D53F031ED53 Q33877217-65C0D1DE-FD7C-4DC2-B66B-9FB2D4F01638 Q33894321-459910EE-1207-4800-8C0E-89EA4209719E Q34031730-9E2964B4-EBCD-40F1-9AB4-E180E7050DF0 Q34080911-54EF67FE-B14A-4F11-901C-B7206F99CEF0 Q34151144-5947581D-C39F-4120-BEA9-15C57CC66E14 Q34189487-2077AC4A-248A-4E44-AE91-BDEC3C770364 Q34274515-BD7F2200-939B-4686-8EEA-D2EA0F7D2C52 Q34287659-D905F30B-4323-4F06-A477-ADECDBB02538 Q34691785-3D5379D3-C5C2-4A12-9588-44772A1DBEFC Q34714252-C47BE27D-B527-444D-A576-18482B112709 Q34983932-17B77E1D-5ADB-4D5D-B1E7-BA3D788B0834 Q35030902-9301D9BE-CF0B-4089-9F8B-80D055BA979E Q35033334-193C9516-EA51-40C7-8562-2EEB7E466A97 Q35104944-08EA8AE4-4B87-4F19-9E63-33B23C1AC0DA Q35129539-6A944AB5-FE31-458C-AE0A-91EC58C3182F Q35131643-54A53A3E-9C84-4F83-8D07-C92784B44FED Q35148074-66DCA120-CC71-491D-BB6D-AA4D2B60B648 Q35210966-A84DFB60-FF96-465F-B462-855E6ED117BE Q35234774-14BC83FF-9A50-4AA9-BD11-BF0CC8244B96 Q35559790-977CC590-A48C-4ADE-B711-BC71879834DD

P2860

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.

http://www.wikidata.org/entity/Q36370322

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Natural killer T cell ligand a ...... y induced by malaria vaccines.

@ast

Natural killer T cell ligand a ...... y induced by malaria vaccines.

@en

type

label

Natural killer T cell ligand a ...... y induced by malaria vaccines.

@ast

Natural killer T cell ligand a ...... y induced by malaria vaccines.

@en

prefLabel

Natural killer T cell ligand a ...... y induced by malaria vaccines.

@ast

Natural killer T cell ligand a ...... y induced by malaria vaccines.

@en

P1433

Q36370322-3BAE5AF4-6BEF-49BC-825F-D017D92C62A7

P1476

Q36370322-059FA25B-DFB7-4D56-BB65-C46B961FDDC6

P2093

Q36370322-50E52A38-3C94-4D83-838C-E15B61DC24A5

Q36370322-B4B2E906-678E-4D69-827A-8D9967EEC575

Q36370322-C9B4EF10-011A-4663-A1DE-6B3D4DA89029

Q36370322-E176962B-0836-4D9D-8A6C-233482ADBD37

Q36370322-F9E4A30F-484D-4184-BA82-EDD461FCCCCD

P2860

Q36370322-04CD1F21-3568-4B1A-ADA9-0AE29D693A48

Q36370322-089F7109-17D0-4C43-966B-D3C381F4FF8B

Q36370322-2367A067-EBF6-4079-907B-DCC5129F2E08

Q36370322-269ADFA3-AE1B-43EF-A08C-65C1C93832D3

Q36370322-2829CB53-233A-45C7-9E7F-0B68FD4B728B

Q36370322-2BC45BDD-3C96-42FD-BD48-4DAB39AA5059

Q36370322-3A68654F-0C5A-4165-8F93-D8E262F4CE24

Q36370322-416D1085-FDA4-4AEC-B873-4391D5474C98

Q36370322-45D0A0C7-4556-440A-B967-E46071825538

Q36370322-46C14BE4-FD7F-4B40-A5C5-7452DAAC180A

P304

Q36370322-210A5DB3-D8ED-4F28-A67F-3C46625B78BC

P31

Q36370322-933E2E5C-B5C5-45EE-BC34-70DF3714CBDC

P356

Q36370322-1F13CFE5-7E86-46AC-926F-39742D56D20A

P407

Q36370322-124AECD8-C768-48F6-8D44-6F71D663E6F2

P433

Q36370322-6826EBD5-013A-45EE-A89C-B8BB25E2BECD

P478

Q36370322-B9E3BAE0-1E64-4BF8-9BD7-706087C63817

P50

Q36370322-0532F540-5D75-4746-A810-F07FDD4B64CA

Q36370322-27F979E6-0975-459B-AC59-6ED4C002E13B

Q36370322-58EB7B83-7365-4B9B-8035-E87F4B372111

Q36370322-A49EED4B-B1E8-4257-8694-B0FC34D44CFD

Q36370322-FFC3B868-1975-45BA-A971-40C3CFD74924

P577

Q36370322-ADEA8E35-DBD9-4FC2-AF2F-9A89C6CF0F25

P5875

Q36370322-B18220AA-1EEA-4625-93EE-1B2C289DFAC0

P698

Q36370322-558BB80E-9797-41EE-8289-E892ABC1B95A

P921

Q36370322-EFF0510E-C67E-48DC-863A-2B4F50344DA7

P932

Q36370322-7F847A71-2A50-4A65-9C7B-2D541418B8E5

P356

P1433

Journal of Experimental Medicine

P1476

Natural killer T cell ligand a ...... y induced by malaria vaccines.

@en

P2093

Gloria Gonzalez-Aseguinolaza

http://www.w3.org/2001/XMLSchema#string

John Schmieg

http://www.w3.org/2001/XMLSchema#string

Masaru Taniguchi

http://www.w3.org/2001/XMLSchema#string

Toshinori Nakayama

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Koezuka

http://www.w3.org/2001/XMLSchema#string

P2860

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei

Common west African HLA antigens are associated with protection from severe malaria

Advances in vaccine adjuvants.

Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice.

A fresh look at tumor immunosurveillance and immunotherapy.

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.

An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factor

P304

617-624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20011889

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

195

http://www.w3.org/2001/XMLSchema#string

P50

Mitchell Kronenberg

Cornelia C. Bergmann

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11484249

http://www.w3.org/2001/XMLSchema#string

P698

11877484

http://www.w3.org/2001/XMLSchema#string

P921

P932

2193764

http://www.w3.org/2001/XMLSchema#string